Trials / Completed
CompletedNCT05459883
Splenic Artery Ligation and Portocaval Shunt in Small-for-size Syndrome
Hemodynamic Modulations to Ameliorate Sinusoidal Injuries After Extended Liver Resections: the Role of Splenic Artery Ligation and Porto-caval Shunt in a Series of Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 13 (actual)
- Sponsor
- Aretaieion University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Our study aimed at assessing the changes of portal vein pressure, portal vein flow and hepatic arterial flow (HAF) in liver remnants ≤ 30% of the standard liver volume by reducing portal vein overflow via ligation of the splenic artery.
Detailed description
It has been reported that prevention of acute portal overpressure in small-for-size liver grafts leads to better postoperative outcomes. Accordingly, we aimed to investigate the feasibility of the technique of splenic artery ligation in a case series of patients subjected to major liver resections with evidence of small-for-size syndrome and whether the maneuver results in reduction of portal venous pressure and flow.
Conditions
- Small-For-Size Liver Syndrome
- Ligation
- Liver Regeneration
- Splenic Artery
- Portal Vein
- Ischemia
- Reperfusion Injury
- Hepatectomy
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | splenic artery ligation | We identified portal hyperperfusion as a cause of potential small-for-size liver remnant dysfunction and we applied splenic artery ligation as a technically simple procedure to manage the situation |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2022-07-15
- Last updated
- 2022-07-15
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT05459883. Inclusion in this directory is not an endorsement.